For AML patients (Figure 4B), scores were heterogeneous, with some patients being strictly MCL-1 dependent (patient 3) and some others showing a strong BCL-XL dependency (patient 2, BCL-XL score = 71.9). This evidence concerns the gene BCL2L1 and acute myeloid leukemia.